Sunday, May 22, 2011

Amiodarone (Teaching Point)

Prescribing information
  • Treatment by mouth
    • 200 mg 3 times daily for 1 week reduced to 200 mg twice daily for a further week.
    • Maintenance dose, usually 200 mg daily or the minimum required to control the arrhythmia.
  • Treatment by intravenous infusion
    • Via a central line, 5 mg/kg over 20-120 minutes with ECG monitoring; maximum 1.2 g in 24 hours.
  • Emergency treatment during cardiopulmonary resuscitation
    • VF or pulseless VT, 300 mg by intravenous injection over at least 3 minutes (pre-filled syringe).
Teaching Point
Drugs with a long half-life. Onset and offset of action.
  • Amiodarone is an example of a drug with a very long half-life (about 50 days). The half-life of a drug is the time taken for the plasma concentration of the drug to fall by half, and is a measure of how quickly a drug is eliminated from the body.
  • When a second dose of a drug is taken, its pharmacokinetic profile is superimposed on that of the first dose, and so on for subsequent doses. For a given dose, the pattern of plasma concentrations that results will depend upon two factors: the dosage interval and the half-life of the drug. A consequence of first-order pharmacokinetics (essentially exponential decay) is that during repeated administration, drug accumulation occurs. This is because the higher the plasma concentration is, the faster it falls. Eventually, during a dosage interval, the plasma concentration falls as fast as it rises. At this point a steady state is reached, after about four half-lives of administration, provided that the dosage interval is not excessively long. Before such a steady state has been reached one cannot say that the drug has reached its maximum effect.
  • The practical consequence of this is that the maximum effect of amiodarone is not reached until about 4 half-lives have elapsed, about 200 days, unless a loading dose is given.
  • It is unwise to declare that a drug is not effective until a steady state has been reached. Prematurely increasing the dose may lead to excessive accumulation and toxicity.
  • In the same way as it takes a very long time for amiodarone to have its maximum effect, it takes a very long time for amiodarone to be eliminated from the body once it has been stopped. Adverse effects and drug interactions can occur weeks after amiodarone has been stopped.
Drugs with long half-lives
  • Bisphosphonates
  • Amiodarone
  • Choloroquine
  • Hydroxychloroquine
  • Gold salts
    • Auranofin
    • Sodium aurothiomalate
  • Alfacalcidol
  • Levothyroxine
  • Digitoxin
  • Phenytoin
  • Fluoxetine
  • Digoxin
  • Warfarin
Years (in bone)
50 days
48 days
18 days
21 days
6 days
14 days
7 days
5 days
Variable, up to 60 hours or more
48 hours
40 hours
24 hours
Amiodarone has a complex mechanism of action that is incompletely understood, but is probably mediated through effects on cardiac potassium channels.
  • Amiodarone prolongs the action potential and refractory period homogeneously throughout the heart.
  • The principal ECG change is a prolongation of the QT interval.
  • Amiodarone is a class III antiarrhythmic drug in the Vaughan-Williams classification.

Advertisements